The 2025 ANSTO Australian Synchrotron Stephen Wilkins Medal
ANSTO is seeking nominations for the ANSTO Australian Synchrotron Stephen Wilkins Thesis Medal.
Showing 1 - 20 of 58 results
ANSTO is seeking nominations for the ANSTO Australian Synchrotron Stephen Wilkins Thesis Medal.
You are invited to submit to the various awards from ANSTO and the User Meeting 2025 organising committee.
ANSTO welcomes the Federal Budget, which supports ongoing operations.
ANSTO's Sydney locations are home to the Open Pool Australian Light-water (OPAL) multi-purpose reactor, the Centre for Accelerator Science (CAS), the Australian Centre for Neutron Scattering, the National Research Cyclotron and the National Deuteration Facility.
Gavinis an executive leader with more than 25 years’ experience across people leadership, operations and business transformation in complex, asset‑intensive organisations.
The International Synchrotron Access Program (ISAP) is administered by the Australian Synchrotron and is designed to assist Australian-based synchrotron users to access overseas synchrotron related facilities.
Frequently asked questions on the Mo-99 Manufacturing Facility and the ANSTO Nuclear Medicine project.
Proposals at the Australian Centre for Neutron Scattering and National Deuteration Facility.
ANSTO can confirm it has completed its 9th successful export of spent fuel. The spent fuel, from OPAL, ANSTO’s multipurpose reactor, has gone to France for reprocessing.
Voucher scheme accelerating medical research
ANSTO has been tracking and publishing data on fine particle pollution from key sites around Australia, and internationally, for more than 20 years.
ANSTO is privileged to be home to an incredible array of outstanding women in science. On the International Day of Women and Girls in Science we wanted to thank each one. Thank you!
ANSTO’s user office in Melbourne offers access to the Australian Synchrotron, a world-class research facility with over 4,000 user visits per year. ANSTO seeks collaboration and partnerships with research organisations, scientific users and commercial users.